Perri, G., Prakash, L., Qiao, W., Varadhachary, G. R., Wolff, R., Fogelman, D., . . . Katz, M. H. G. (2020). Response and Survival Associated With First-line FOLFIRINOX vs Gemcitabine and nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma. JAMA Surg.
Citação norma ChicagoPerri, Giampaolo, et al. "Response and Survival Associated With First-line FOLFIRINOX Vs Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma." JAMA Surg 2020.
Citação norma MLAPerri, Giampaolo, et al. "Response and Survival Associated With First-line FOLFIRINOX Vs Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma." JAMA Surg 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.